Cambridge, April 2020: Plextek Services Ltd and Design Momentum Ltd are pleased to announce they have entered into a strategic partnership to develop scientific instruments and laboratory equipment for life sciences. The partnership brings together Plextek’s expertise in electronic engineering design & development at its ISO13485-certified premises with Design Momentum’s 25 years of experience in innovative technology design in the sector.

The life science industry continues to experience change and rapid growth. It is now more than ever vital for instrumentation companies to embrace new technologies, improve efficiencies and productivity, and move to meet the ever-increasing demands of the sector. The Plextek-DM partnership brings together deep skills and experience in product ideation, industrial design, technology development and manufacture, and will allow clients to advance using the latest technologies, speeding time to market.

Current events are showing only too well the need for rapid development of critical technology to support the life science industry, and this partnership is ideally placed to help its clients through a seamless process from design to the market.

“The Plextek-DM partnership provides a unique one-stop opportunity for life science companies to access all the skills necessary for product development, from inception through to product manufacture”, said Nicholas Hill, Plextek’s CEO. “The alliance brings together a powerful combination of skills in the laboratory equipment sector and builds on the two organisations’ previous collaborations. DM’s collaborative approach is uniquely complementary to how we work within Plextek, and we look forward to a long and fruitful partnership”.

“Partnering with Plextek to design and deliver instrumentation for our clients will allow us to provide the very best design and engineering services,” said Professor Phil Gray, DM’s Managing Director. “Together, working as one team, we will unlock the full potential of our organisations and place our clients on the best path for success in a rapidly changing market.”

Our joint approach to scientific instrumentation development will grant life science clients access to a unique combination of long-term engineering know-how and best-in-class product design capability which will enable next-generation devices to be produced more efficiently, bringing products to a market quickly.

About Plextek Services Ltd
Plextek is an innovative electronic engineering consultancy with huge expertise in advanced sensing, data collection and communications technology. The company has extensive experience of developing highly complex and innovative products for a range of sectors, including medical & healthcare. In a world of rapid change, the company prides itself on its ability to solve the hardest engineering problems to deliver effective solutions to meet our clients’ needs.

About Design Momentum
DM is a user-focused industrial design and product development consultancy helping clients innovate and develop the next generation of products, systems and services. The company brings together a highly-experienced team with a unique blend of creativity, innovation and development skills all with a sharp business focus. DM has combined 72 years of experience in life sciences, automation and scientific instrument design & development.

Please contact Nigel Whittle, Head of Medical & Healthcare at Plextek for more information.

3rd April 2020: Dr Nigel Whittle, Head of Healthcare & Medical at technology consultancy Plextek features in The Engineer news article on how advances in health sensing and monitoring tech could help with remote care for those in self isolation or vulnerable situations.

Coronavirus has taken us all by surprise, with many parts of the world in or heading into virtual lockdown. Can developments in tech and healthcare devices now come into their own and help us fight back against the current crisis?

We are only too aware that early detection is absolutely key to monitoring the spread of disease and ultimately improving survival rates, so how can these developments in devices come into play, now so desperately needed?

To read the full article Click Here.

remote health monitoring device

Nigel Whittle, Head of Medical & Healthcare, features in Health Tech Digital this week.

We are all only too aware that early detection is absolutely key to improving the survival rates of serious illness and disease, never more so when it comes to cancer and other life-threatening conditions. But how can developments in tech and healthcare devices catapult this critical part of our wellbeing into useful reality?

To read the full article click here.

WHO World Hearing Day is held on 3rd March every year to raise awareness on how to prevent deafness and hearing loss and promote ear and hearing care across the world.

This year the theme is the importance of early identification and intervention for hearing loss. It is a fact that many people live with unidentified hearing loss, unaware that they are missing out on certain sounds and words.

The WHO’s key messages are that:

  • Everybody should check their hearing regularly, especially those who are at a higher risk of hearing loss.
  • Services for early identification and intervention should be made available throughout the health system.
  • To address this issue, on 3rd March WHO will launch a free app, hearWHO, that allows people to perform a basic test on their hearing. Although simple, the WHO app is based on validated digits-in-noise technology. This app allows the general public to check their hearing status and monitor it over time, clearly displaying users’ results in a personalized record of hearing status.

The HearWHO app will help:

  • Raise awareness of the importance of hearing.
  • Encourage people to monitor their hearing regularly and practice safe listening.
  • Allow community health workers to check the hearing status of patients.


world health organisation, WHO, hearing loss app, WHO app

Plextek Strongly Supports WHO World Hearing Day

Plextek has a long-standing interest in detection and diagnosis of all forms of hearing loss, and in particular Noise Induced Hearing Loss (NIHL) and tinnitus.

Innovative technology under development by the company could soon have a far reaching impact on the early diagnosis and treatment of a variety of debilitating hearing disorders. Existing systems used to detect hearing disorders are currently restricted for use within clinical environments and are therefore only used during intermittent health checks or when patients are already experiencing advanced symptoms.

Plextek’s technology works by accurately monitoring subtle changes to ‘Auditory Evoked Potentials’ (AEP) – a signal sent from the brain by an acoustical stimulus that measures an individual’s auditory ability level. It has been demonstrated to reliably detect the early signs of tinnitus – well before a person would become aware of the symptoms.

Integration of Plextek’s solution into commonly used consumer headphones removes the clinical barrier and can play a game-changing preventative role, particularly benefitting those within high-risk environments such as loud noise environments, the military or music venues. By syncing with a smartphone app the technology could also be used to alert the wearer to a potential problem and encourage them to seek out early medical help or take preventative action.

Key Facts about Hearing Loss

  • Around 466 million people worldwide have disabling hearing loss, and it is estimated that by 2050 over 900 million people will have disabling hearing loss.
  • Hearing loss may result from genetic causes, complications at birth, chronic ear infections or infectious disease, the use of particular drugs, exposure to excessive noise, and ageing.
  • 1.1 billion young people (aged between 12–35 years) are at risk of hearing loss due to exposure to excessive noise in recreational settings.
  • Unaddressed hearing loss poses an annual global cost of US$ 750 billion, while interventions to prevent, identify and address hearing loss are highly cost-effective.
  • People with potential hearing loss benefit from early identification and diagnosis.